Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA: 600521)

Zhejiang Huahai Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,591	1,342	1,365	1,876	2,212	1,504
Short-Term Investments	-	-	-	-	-	2
Trading Asset Securities	64.62	93.04	143.07	1.01	-	-
Cash & Short-Term Investments	1,656	1,435	1,508	1,877	2,212	1,506
Cash Growth	-17.64%	-4.82%	-19.66%	-15.12%	46.82%	65.40%
Accounts Receivable	2,954	2,557	2,831	1,906	1,757	1,404
Other Receivables	22.85	28.4	47.43	40.85	39.85	20.56
Receivables	2,977	2,585	2,879	1,947	1,797	1,424
Inventory	3,237	3,432	3,375	2,739	2,368	2,217
Prepaid Expenses	4.49	4.25	-	-	0	0.02
Other Current Assets	246.33	164.61	145.35	250.18	145.84	119.07
Total Current Assets	8,120	7,622	7,907	6,813	6,523	5,267
Property, Plant & Equipment	8,284	7,994	7,307	5,961	4,366	3,803
Long-Term Investments	761.03	785.25	863.17	1,027	641.78	495.43
Goodwill	64.45	64.45	70.9	70.9	70.9	70.9
Other Intangible Assets	1,210	1,113	1,072	970.6	806.93	647.94
Long-Term Deferred Tax Assets	185.46	171.99	183.9	110.15	175.73	123.63
Long-Term Deferred Charges	882.61	843.04	737.88	508.28	387.7	310.8
Other Long-Term Assets	5.91	6.45	9.46	7.87	18.51	10.91
Total Assets	19,513	18,600	18,152	15,468	12,991	10,729
Accounts Payable	1,526	1,387	1,203	881.79	894.34	577.04
Accrued Expenses	936.33	735.43	898.42	791.6	471.8	270.66
Short-Term Debt	1,885	1,583	1,397	1,314	1,005	1,417
Current Portion of Long-Term Debt	1,019	1,191	630.76	630.99	123.83	710.97
Current Portion of Leases	15.08	16.82	16.72	13.82	-	-
Current Income Taxes Payable	56.66	91.14	264.11	187.9	165.71	38.06
Current Unearned Revenue	34.73	33.51	67.7	66.71	40.09	-
Other Current Liabilities	240.92	407.71	321.64	348.93	190.42	342.89
Total Current Liabilities	5,713	5,445	4,799	4,236	2,891	3,357
Long-Term Debt	3,943	4,022	4,678	3,498	2,921	1,179
Long-Term Leases	37.97	44.93	59.14	66.41	-	-
Long-Term Unearned Revenue	690.23	665.44	532.09	448.44	299.36	292.2
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.08
Other Long-Term Liabilities	164.77	171.02	338	443.51	155.3	122.14
Total Liabilities	10,549	10,349	10,406	8,692	6,267	4,951
Common Stock	1,467	1,483	1,483	1,492	1,455	1,322
Additional Paid-In Capital	1,170	1,296	1,322	1,381	1,040	1,162
Retained Earnings	6,221	5,470	4,992	3,971	3,774	3,109
Treasury Stock	-300.05	-416.91	-484.25	-521.84	-	-
Comprensive Income & Other	245.18	244.43	233.98	236.54	243.73	16.39
Total Common Equity	8,802	8,077	7,547	6,559	6,513	5,610
Minority Interest	161.84	174.26	199.07	217.48	211.14	169.11
Shareholders' Equity	8,964	8,251	7,746	6,776	6,724	5,779
Total Liabilities & Equity	19,513	18,600	18,152	15,468	12,991	10,729
Total Debt	6,900	6,858	6,782	5,523	4,050	3,308
Net Cash (Debt)	-5,244	-5,422	-5,273	-3,646	-1,838	-1,801
Net Cash Per Share	-3.63	-3.74	-3.61	-2.54	-1.26	-1.30
Filing Date Shares Outstanding	1,449	1,468	1,473	1,484	1,455	1,455
Total Common Shares Outstanding	1,449	1,468	1,473	1,484	1,455	1,455
Working Capital	2,407	2,176	3,109	2,577	3,632	1,910
Book Value Per Share	5.91	5.34	4.96	4.26	4.31	3.86
Tangible Book Value	7,528	6,899	6,403	5,517	5,635	4,891
Tangible Book Value Per Share	5.03	4.54	4.18	3.56	3.71	3.36
Buildings	3,866	3,757	2,839	2,151	-	1,898
Machinery	5,815	175.56	152.08	3,827	-	2,851
Construction In Progress	2,584	2,317	2,803	2,502	-	929.85

Source: S&P Capital IQ. Standard template. Financial Sources.